Home NDC 69117-0021-01 NDC 69117-0021-01 - Celecoxib This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 69117-0021
Requested NDC 69117-0021-01
Package NDCs from labels 69117-0021-1, 69117-0021-2, 69117-0021-3, 69117-0021-01
Manufacturer Yiling Pharmaceutical, Inc. | Yiling Pharmaceutical Ltd
Effective date 2025-12-29
Current FDA listing Not matched in FDA.report NDC product tables
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69117-0021-1 Celecoxib 60 in 1 BOTTLE CAPSULE 60 10 69117-0021-2 Celecoxib 100 in 1 BOTTLE CAPSULE 100 10 69117-0021-3 Celecoxib 500 in 1 BOTTLE CAPSULE 500 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69117-0021 CELECOXIB CAPSULE [YILING PHARMACEUTICAL, INC.] 9 Current NDC, Legacy NDC, 3 package rows 20250101_43979279-867b-4303-8f30-fc58ae75a069.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 116 · 2,311 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join HERA SILKYSTAY FOUNDATION 48N1 TITANIUM DIOXIDE Amorepacific Corporation 5f4372c4-b87a-91ab-e063-6294a90a6807 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 49C1 TITANIUM DIOXIDE Amorepacific Corporation 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP Celecoxib CELECOXIB Direct_Rx 4b2ffbdb-1847-d93b-e063-6394a90a06f5 2026-10-30 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 205322 unii: JCX84Q7J1L Celecoxib CELECOXIB Unichem Pharmaceuticals (USA), Inc. 0e8484a8-04a6-4be3-8c5c-1883b0490d53 2026-10-30 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 686379 rxcui: 205323 rxcui: 349514 rxcui: 205322 unii: JCX84Q7J1L Celecoxib CELECOXIB Direct_Rx 5eff2336-7e06-d5ca-e063-6394a90aa3c7 2026-10-29 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 205323 unii: JCX84Q7J1L HERA BLACK CUSHION FOUNDATION 13N1 OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE Amorepacific Corporation 5aff3d25-d034-0815-e063-6294a90a8664 2026-10-29 Warnings Exact identifier unii: 15FIX9V2JP Blue Lizard Sensitive SPF 50 Sunscreen TITANIUM DIOXIDE AND ZINC OXIDE Crown Laboratories 32d78048-d281-1d80-e063-6394a90aec19 2026-10-28 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 32W1 TITANIUM DIOXIDE Amorepacific Corporation 5eed2165-afc2-6958-e063-6294a90add58 2026-10-28 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 34O1 TITANIUM DIOXIDE Amorepacific Corporation 5eedd87b-a7b1-1abc-e063-6294a90ae29e 2026-10-28 Warnings Exact identifier unii: 15FIX9V2JP CELECOXIB CELECOXIB NIVAGEN PHARMACEUTICALS, INC. ae7943ab-b1fc-f08f-e053-2995a90a051e 2026-10-26 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 686379 rxcui: 205323 rxcui: 349514 rxcui: 205322 unii: JCX84Q7J1L HERA SILKYSTAY FOUNDATION 26N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec7151e-4f83-4aca-e063-6294a90a9818 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 26W1 TITANIUM DIOXIDE Amorepacific Corporation 5ec7276d-fcaf-65b2-e063-6394a90ac220 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 28C1 TITANIUM DIOXIDE Amorepacific Corporation 5ec73566-5d67-7153-e063-6394a90aba33 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 28N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec75100-153c-80cd-e063-6294a90a6d51 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 28O1 TITANIUM DIOXIDE Amorepacific Corporation 5ec77f7a-4621-ac0c-e063-6294a90a3f70 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 29N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec7ab15-9cc1-d53a-e063-6294a90a4111 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 29W1 TITANIUM DIOXIDE Amorepacific Corporation 5ec83b87-08bc-7590-e063-6294a90a0b78 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 31C1 TITANIUM DIOXIDE Amorepacific Corporation 5ec857a3-7fd1-6461-e063-6394a90aacd7 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 31N1 TITANIUM DIOXIDE Amorepacific Corporation 5ec871dc-f74e-765c-e063-6394a90a27a5 2026-10-26 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 13N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb19976-6983-3d9e-e063-6394a90a01ee 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.